Because targeting purinergic receptors appears to be equivalently effective at blocking cell-free and cell-to-cell infection, these are attractive targets; inhibition of cell-to-cell infection with some ART can exhibit diminished efficacy (128–130). This evidence concerns the gene P2RX1 and infection.